Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 09, 2017 07:03 ET | Source: Neuralstem, Inc.

Neuralstem Announces Publication of NSI-566 Data in a Rodent Model of Traumatic Brain Injury

-NSI-566 Achieved Robust Engraftment and Long-Term Survival After Transplantation- - Data Published in Journal of Neurotrauma- GERMANTOWN, Md., March 09, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc....
March 08, 2017 07:03 ET | Source: Neuralstem, Inc.

Neuralstem to Present at 29th Annual ROTH Conference

GERMANTOWN, Md., March 08, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell...
March 01, 2017 02:14 ET | Source: Neuralstem, Inc.

Neuralstem Umum Penerbitan Data Praklinikal NSI-189 dalam Jurnal Fisiologi Selular

-NSI-189 Buktikan Pemulihan Fungsi Tahan Lama dalam Model Tikus (Roden) bagi Strok Iskemik --NSI-189 Galakkan Pemodelan Semula Sinaps Selepas Strok-GERMANTOWN, Md., March 01, 2017 (GLOBE NEWSWIRE)...
March 01, 2017 02:14 ET | Source: Neuralstem, Inc.

ニューラルステム、ジャーナル･オブ･セルラー･フィジオロジーに、NSI-189前臨床データの公表を発表

-NSI-189のデータは、げっ歯類モデルで虚血性脳梗塞の持続的機能回復を示した--NSI-189は、脳梗塞後のシナプスのリモデリングを促進した-メリーランド州ジャーマンタウン発, March 01, 2017 (GLOBE NEWSWIRE) -- 神経幹細胞技術を基盤とする中枢神経系療法の開発に取り組むバイオ製薬企業、ニューラルステム (Neuralstem、NASDAQ:CUR)...
March 01, 2017 02:14 ET | Source: Neuralstem, Inc.

뉴럴스템, 세포생리학誌에 NSI-189 전임상 데이터 발표

-NSI-189, 허혈성 뇌졸중 쥐 모델에서 꾸준한 기능 회복 효능--뇌졸중 후 시냅스 리모델링 증진 효과도 확인-메릴랜드주 저먼타운, March 01, 2017 (GLOBE NEWSWIRE) -- 바이오 제약사 뉴럴스템(Neuralstem, Inc.)(나스닥 거래명:CUR)이 NSI-189에 대한 최신 전임상 데이터 보고서를...
March 01, 2017 02:14 ET | Source: Neuralstem, Inc.

Neuralstem宣布在《细胞生理学杂志》上发表NSI-189临床前数据

-NSI-189显示了在缺血性中风啮齿动物模型中的持久性功能恢复--NSI-189促进了中风后的突触重塑-马里兰州日耳曼敦, March 01, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc.（Nasdaq代码：CUR），一家专门开发基于其神经干细胞技术的神经系统治疗的生物制药公司，宣布最近在《细胞生理学杂志》（Journal of Cellular...
March 01, 2017 02:14 ET | Source: Neuralstem, Inc.

Neuralstem宣佈在《細胞生理學雜誌》上發表NSI-189臨床前數據

-NSI-189顯示了在缺血性中風齧齒動物模型中的持久性功能恢復--NSI-189促進了中風後的突觸重塑-馬裡蘭州日耳曼敦, March 01, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc.（Nasdaq代號：CUR），一家專門開發基於其神經幹細胞技術的神經系統治療的生物製藥公司，宣佈最近在《細胞生理學雜誌》（Journal of Cellular...
February 28, 2017 07:03 ET | Source: Neuralstem, Inc.

Neuralstem Announces Publication of NSI-189 Preclinical Data in Journal of Cellular Physiology

-NSI-189 Showed Durable Functional Recovery in a Rodent Model of Ischemic Stroke- -NSI-189 Promoted Synaptic Remodeling After Stroke- GERMANTOWN, Md., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Neuralstem,...
February 22, 2017 07:03 ET | Source: Neuralstem, Inc.

Neuralstem Announces Issuance of U.S. Patent Covering NSI-189

GERMANTOWN, Md., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of central nervous system therapies based on its neural stem...
February 17, 2017 04:38 ET | Source: Neuralstem, Inc.

ニューラルステム (Neuralstem)、大鬱病性障害のためのNSI-189の第II相治験に最終の被験者組み入れが完了したことを発表

－第II相のデータは、2017年第3四半期に予定よりも早く取得できる見込みメリーランド州ジャーマンタウン発, Feb. 17, 2017 (GLOBE NEWSWIRE) -- 神経幹細胞技術を基盤とする中枢神経系療法の開発に取り組むバイオ製薬企業、ニューラルステム (Neuralstem, Inc.、Nasdaq:CUR) は本日、大鬱病性障害 (MDD)...